Optimal timing of SARS-CoV-2 vaccination prior to cardiovascular surgery under cardiopulmonary bypass.
Ryosuke HayashiYoshiyuki TakamiHidetsugu FujigakiKentaro AmanoKiyotoshi AkitaKoji YamanaAtsuo MaekawaKuniaki SaitoYasushi TakagiPublished in: The International journal of artificial organs (2024)
Although 40% of the RBD-IgG titers reduce 1 day after CPB surgery, the patients who received the SARS-COV-2 vaccination within an 81-day window prior to the surgery maintained a desirable RBD-IgG level, even up to 1 month after surgery. It may be important to schedule the surgery no later than 81 days after the vaccination.